ARHGEF15

Chr 17AD

Rho guanine nucleotide exchange factor 15

Also known as: ARGEF15, BSVD5, E5, Ephexin5, Vsm-RhoGEF

This protein functions as a guanine nucleotide exchange factor that specifically activates RhoA, regulating actin cytoskeleton organization, vascular smooth muscle contractility, and excitatory synapse development. Mutations cause brain small vessel disease 5 with osteoporosis, affecting both the cerebrovascular system and bone metabolism. The condition follows autosomal dominant inheritance and the gene is highly constrained against loss-of-function variants (LOEUF 0.665).

OMIMResearchSummary from RefSeq, OMIM, UniProt
MultiplemechanismADLOEUF 0.671 OMIM phenotype
Clinical SummaryARHGEF15
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
15 unique Pathogenic / Likely Pathogenic· 243 VUS of 451 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.67LOEUF
pLI 0.000
Z-score 3.15
OE 0.44 (0.300.67)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
0.71Z-score
OE missense 0.91 (0.840.98)
475 obs / 520.9 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.44 (0.300.67)
00.351.4
Missense OE0.91 (0.840.98)
00.61.4
Synonymous OE0.91
01.21.6
LoF obs/exp: 16 / 36.5Missense obs/exp: 475 / 520.9Syn Z: 1.04
DN
0.6261th %ile
GOF
0.72top 25%
LOF
0.3647th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

451 submitted variants in ClinVar

Classification Summary

Pathogenic15
VUS243
Likely Benign169
Benign17
Conflicting4
15
Pathogenic
243
VUS
169
Likely Benign
17
Benign
4
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
15
0
15
Likely Pathogenic
0
0
0
0
0
VUS
9
214
19
1
243
Likely Benign
0
6
66
97
169
Benign
0
5
7
5
17
Conflicting
4
Total9225107103448

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

ARHGEF15 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →